Yamanouchi K, Shinozaki T, Chikada K, Nishikawa T, Ito K, Shimizu S, Ozawa N, Suzuki Y, Maeno H, Kato K
First Department of Internal Medicine, Aichi Medical University, Japan.
Diabetes Care. 1995 Jun;18(6):775-8. doi: 10.2337/diacare.18.6.775.
To evaluate the effects of walking combined with diet therapy (1,000-1,600 kcal/day) on insulin sensitivity in obese non-insulin-dependent diabetes mellitus (NIDDM) patients.
Subjects were divided into two groups: 10 patients were managed by diet alone (group D), and 14 patients were placed in the diet and exercise group (group DE). Group DE was instructed to walk at least 10,000 steps/day on a flat field as monitored by pedometer (19,200 +/- 2,100 steps/day), and group D was told to maintain a normal daily routine (4,500 +/- 290 steps/day). A glucose clamp procedure at an insulin infusion rate of 40 microU.min-2.min-1 was performed before and after the 6- to 8-week training program. Mean serum insulin concentrations ranged from 720 to 790 pmol/l.
While body weight (BW) in groups D and DE decreased significantly (P < 0.01) during the study, the amount of BW reduction in group DE was greater than that in group D (7.8 +/- 0.8 vs. 4.2 +/- 0.5 kg, P < 0.01). After training, glucose infusion rate (GIR) and metabolic clearance rate (MCR) in group D did not significantly increase; however, GIR and MCR increased significantly in group DE, from 17.21 +/- 1.11 to 26.09 +/- 1.11 mumol.kg-1.min-1 (P < 0.001) and from 3.0 +/- 0.3 to 5.3 +/- 0.4 ml.kg-1.min-1 (P < 0.001), respectively. The analysis of variance showed significant effects of exercise (time x exercise, P = 0.0005) for the improvement of MCR. Significant correlations were also observed between delta MCR and average steps per day (r = 0.7257, P < 0.005) in group DE.
Walking, which can be safely performed and easily incorporated into daily life, can be recommended as an adjunct therapy to diet treatment in obese NIDDM patients, not only for BW reduction, but also for improvement of insulin sensitivity.
评估步行联合饮食疗法(每日1000 - 1600千卡)对肥胖非胰岛素依赖型糖尿病(NIDDM)患者胰岛素敏感性的影响。
将受试者分为两组:10例患者仅接受饮食管理(D组),14例患者进入饮食与运动组(DE组)。指导DE组在平坦场地每天至少步行10000步,通过计步器监测(每天19200±2100步),D组被告知保持日常正常活动量(每天4500±290步)。在为期6至8周的训练计划前后,以40微单位·分钟⁻²·分钟⁻¹的胰岛素输注速率进行葡萄糖钳夹试验。平均血清胰岛素浓度范围为720至790皮摩尔/升。
在研究期间,D组和DE组的体重(BW)均显著下降(P < 0.01),但DE组的体重减轻量大于D组(7.8±0.8对4.2±0.5千克,P < 0.01)。训练后,D组的葡萄糖输注速率(GIR)和代谢清除率(MCR)未显著增加;然而,DE组的GIR和MCR显著增加,分别从17.21±1.11增加至26.09±1.11微摩尔·千克⁻¹·分钟⁻¹(P < 0.001)和从3.0±0.3增加至5.3±0.4毫升·千克⁻¹·分钟⁻¹(P < 0.001)。方差分析显示运动对MCR的改善有显著影响(时间×运动,P = 0.0005)。在DE组中,还观察到MCR的变化量与每天平均步数之间存在显著相关性(r = 0.7257,P < 0.005)。
步行安全可行且易于融入日常生活,可推荐作为肥胖NIDDM患者饮食治疗的辅助疗法,不仅有助于减轻体重,还能改善胰岛素敏感性。